XML 46 R35.htm IDEA: XBRL DOCUMENT v3.25.3
Stock Options Restricted Stock (Tables)
9 Months Ended
Sep. 30, 2025
Stock Options and Restricted Stock  
Summary of weighted average assumptions used in the model for valuing stock option grants

The weighted average assumptions used in the model for valuing stock options grants for the nine months ended September 30, 2025 are as follows:

September 30, 

    

2025

    

Dividend Yield

 

%  

Expected Life

 

7

Years

Expected Volatility

 

30.83

%  

Risk-Free Interest Rate

 

4.42

%  

Summary of the status of the Company's outstanding stock options

The following table presents a summary of the status of the Company’s outstanding stock options for the nine months ended September 30, 2025:

September 30, 2025

    

    

    

Weighted

Average

Shares

Exercise Price

Outstanding at Beginning of Year

 

1,860,609

$

10.69

Granted

 

275,000

 

13.77

Exercised

 

(148,738)

 

8.39

Forfeitures

 

(16,500)

 

12.94

Outstanding at Period End

 

1,970,371

$

11.28

Options Exercisable at Period End

 

1,396,745

$

10.52

Summary of information pertaining to options outstanding based on range of exercise price

The following table presents information pertaining to options outstanding at September 30, 2025:

Options Outstanding

Options Exercisable

Weighted Average

Number of

Weighted Average

Remaining Contractual

Number of

Weighted Average

Range of Exercise Prices

    

Options

    

Exercise Price

Life in Years

Options

    

Exercise Price

$

7.00 - 7.99

 

714,438

 

$

7.47

 

2.0

 

714,438

 

$

7.47

8.00 - 8.99

 

2,961

 

8.76

 

4.5

 

2,961

 

8.76

10.00 - 10.99

204,250

10.62

7.7

96,499

10.59

11.00 - 11.99

229,125

11.16

6.5

117,000

11.22

12.00 - 12.99

249,097

12.91

3.8

249,097

12.91

13.00 - 13.99

285,000

13.75

9.3

2,500

12.91

17.00 - 17.99

285,500

17.50

6.3

214,250

17.50

Totals

 

1,970,371

$

11.28

5.0

 

1,396,745

$

10.52

Summary of analysis of nonvested options to purchase shares of the Company's stock issued and outstanding

The following table presents an analysis of nonvested options to purchase shares of the Company’s stock issued and outstanding for the nine months ended September 30, 2025:

    

    

    

Weighted

Number of

Average Grant

Shares

Date Fair Value

Nonvested Options at December 31, 2024

 

437,501

$

5.18

Granted

 

275,000

5.83

Vested

 

(129,000)

5.33

Forfeited

(9,875)

4.85

Nonvested Options at September 30, 2025

 

573,626

$

5.46

Summary of the status of the Company's outstanding restricted stock units

The following table presents an analysis of nonvested restricted stock units outstanding for the nine months ended September 30, 2025:

    

    

    

Weighted

Number of

Average Grant

Units

Date Fair Value

Nonvested at December 31, 2024

 

415,758

$

14.46

Granted

 

55,355

13.78

Vested

 

(38,962)

14.12

Forfeited

(8,398)

14.39

Nonvested at September 30, 2025

 

423,753

$

14.40